Chutong Tian

473 total citations
27 papers, 355 citations indexed

About

Chutong Tian is a scholar working on Biomaterials, Molecular Biology and Oncology. According to data from OpenAlex, Chutong Tian has authored 27 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomaterials, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Chutong Tian's work include Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (10 papers) and Drug Transport and Resistance Mechanisms (5 papers). Chutong Tian is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (10 papers) and Drug Transport and Resistance Mechanisms (5 papers). Chutong Tian collaborates with scholars based in China, Japan and United Arab Emirates. Chutong Tian's co-authors include Ken‐ichiro Kamei, Shunzhe Zheng, Zhonggui He, Jin Sun, Xinying Liu, Bingjun Sun, Guanting Li, Xuanbo Zhang, Jianbin Shi and Yifan Miao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Engineering Journal and Journal of Controlled Release.

In The Last Decade

Chutong Tian

25 papers receiving 352 citations

Peers

Chutong Tian
Chutong Tian
Citations per year, relative to Chutong Tian Chutong Tian (= 1×) peers Chenming Zou

Countries citing papers authored by Chutong Tian

Since Specialization
Citations

This map shows the geographic impact of Chutong Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chutong Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chutong Tian more than expected).

Fields of papers citing papers by Chutong Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chutong Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chutong Tian. The network helps show where Chutong Tian may publish in the future.

Co-authorship network of co-authors of Chutong Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Chutong Tian. A scholar is included among the top collaborators of Chutong Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chutong Tian. Chutong Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Jianbin, Dan Li, Jiao Xue, et al.. (2025). Cancer-targeting drug conjugates drives a new era in precise cancer treatment. Chinese Chemical Letters. 37(2). 110960–110960. 2 indexed citations
2.
Sun, Yixin, Baoyuan Zhang, Jiayao Wang, et al.. (2025). Robust antitumor treatment driven by lock-and-key biorecognition of dynamic cyclic diselenide-guided chiral prodrug self-assembly. Cell chemical biology. 32(8). 1013–1027.e5.
3.
Liu, Xinying, Jiaxin Zhang, Shunzhe Zheng, et al.. (2024). Hybrid adipocyte-derived exosome nano platform for potent chemo-phototherapy in targeted hepatocellular carcinoma. Journal of Controlled Release. 370. 168–181. 11 indexed citations
4.
Shi, Jianbin, Wenjing Ma, Shunzhe Zheng, et al.. (2024). Self-assembled hyaluronic acid nanomicelle for enhanced cascade cancer chemotherapy via self-sensitized ferroptosis. Carbohydrate Polymers. 343. 122489–122489. 12 indexed citations
5.
Zheng, Shunzhe, et al.. (2024). Dual-targeted nanoparticulate drug delivery systems for enhancing triple-negative breast cancer treatment. Journal of Controlled Release. 371. 371–385. 9 indexed citations
6.
Ma, Wenjing, et al.. (2024). Ferroptosis inducers: A new frontier in cancer therapy. Bioorganic Chemistry. 146. 107331–107331. 21 indexed citations
7.
Miao, Yifan, Jinrui Liu, Jia Deng, et al.. (2024). Enabling oral novel Taxanes-based Chemotherapy with Lipophilic prodrug Self-nanoemulsifying drug delivery system. Bioorganic Chemistry. 153. 107902–107902. 2 indexed citations
8.
Zhang, Mingyang, Yifan Miao, Tong Liu, et al.. (2024). Fine-tuning the activation behaviors of ternary modular cabazitaxel prodrugs for efficient and on-target oral anti-cancer therapy. Asian Journal of Pharmaceutical Sciences. 19(2). 100908–100908. 6 indexed citations
9.
Li, Guanting, Shuwen Fu, Xuanbo Zhang, et al.. (2023). Smart stimuli-responsive carrier-free nanoassembly of SN38 prodrug as efficient chemotherapeutic nanomedicine. SHILAP Revista de lepidopterología. 2(1). 20 indexed citations
10.
Li, Guanting, Shunzhe Zheng, Shuwen Fu, et al.. (2023). Fine-tuning the structure-tolerance-antitumor efficacy axis of prodrug nanoassemblies via branched aliphatic functionalization. Nano Research. 17(4). 2908–2918. 7 indexed citations
11.
Zheng, Shunzhe, Guanting Li, Jianbin Shi, et al.. (2023). Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy. Journal of Controlled Release. 361. 819–846. 22 indexed citations
12.
Tian, Chutong, Yifan Miao, Helin Wang, et al.. (2022). Long chain triglyceride-lipid formulation promotes the oral absorption of the lipidic prodrugs through coincident intestinal behaviors. European Journal of Pharmaceutics and Biopharmaceutics. 176. 122–132. 10 indexed citations
13.
Tian, Chutong, Shunzhe Zheng, Xinying Liu, & Ken‐ichiro Kamei. (2022). Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system. Journal of Nanobiotechnology. 20(1). 338–338. 44 indexed citations
14.
Wang, Tao, Zhao Chen, Linlin Cao, et al.. (2022). A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension. Asian Journal of Pharmaceutical Sciences. 17(6). 938–948. 5 indexed citations
15.
Tao, Wenhui, Dongyang Zhao, Guanting Li, et al.. (2021). Artificial tumor microenvironment regulated by first hemorrhage for enhanced tumor targeting and then occlusion for synergistic bioactivation of hypoxia-sensitive platesomes. Acta Pharmaceutica Sinica B. 12(3). 1487–1499. 23 indexed citations
16.
Wang, Helin, Jin Sun, Chutong Tian, & Zhonggui He. (2021). Probing the new strategy for the oral formulations of taxanes: changing the method with the situation. Chinese Journal of Natural Medicines. 19(9). 656–665. 6 indexed citations
17.
Tian, Chutong, Yifan Miao, Shunzhe Zheng, et al.. (2021). Triglyceride-Mimetic Structure-Gated Prodrug Nanoparticles for Smart Cancer Therapy. Journal of Medicinal Chemistry. 64(21). 15936–15948. 17 indexed citations
18.
Liu, Kai, Jiang Yu, Xue Wang, et al.. (2019). A solvent-assisted active loading technology to prepare gambogic acid and all-trans retinoic acid co-encapsulated liposomes for synergistic anticancer therapy. Drug Delivery and Translational Research. 10(1). 146–158. 16 indexed citations
20.
Sun, Yixin, Jin Sun, Zhonggui He, et al.. (2019). Monocarboxylate Transporter 1 in Brain Diseases and Cancers. Current Drug Metabolism. 20(11). 855–866. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026